| UniProt ID | QOR_HUMAN | |
|---|---|---|
| UniProt AC | Q08257 | |
| Protein Name | Quinone oxidoreductase | |
| Gene Name | CRYZ | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 329 | |
| Subcellular Localization | Cytoplasm . | |
| Protein Description | Does not have alcohol dehydrogenase activity. Binds NADP and acts through a one-electron transfer process. Orthoquinones, such as 1,2-naphthoquinone or 9,10-phenanthrenequinone, are the best substrates (in vitro). May act in the detoxification of xenobiotics. Interacts with (AU)-rich elements (ARE) in the 3'-UTR of target mRNA species. Enhances the stability of mRNA coding for BCL2. NADPH binding interferes with mRNA binding.. | |
| Protein Sequence | MATGQKLMRAVRVFEFGGPEVLKLRSDIAVPIPKDHQVLIKVHACGVNPVETYIRSGTYSRKPLLPYTPGSDVAGVIEAVGDNASAFKKGDRVFTSSTISGGYAEYALAADHTVYKLPEKLDFKQGAAIGIPYFTAYRALIHSACVKAGESVLVHGASGGVGLAACQIARAYGLKILGTAGTEEGQKIVLQNGAHEVFNHREVNYIDKIKKYVGEKGIDIIIEMLANVNLSKDLSLLSHGGRVIVVGSRGTIEINPRDTMAKESSIIGVTLFSSTKEEFQQYAAALQAGMEIGWLKPVIGSQYPLEKVAEAHENIIHGSGATGKMILLL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MATGQKLMR ------CCHHHHHHH | 22.04 | 22814378 | |
| 6 | Acetylation | --MATGQKLMRAVRV --CCHHHHHHHHHHH | 45.66 | 23749302 | |
| 6 | Ubiquitination | --MATGQKLMRAVRV --CCHHHHHHHHHHH | 45.66 | 24816145 | |
| 23 | Acetylation | FGGPEVLKLRSDIAV CCCHHHEEEECCEEE | 47.21 | 19608861 | |
| 23 | Ubiquitination | FGGPEVLKLRSDIAV CCCHHHEEEECCEEE | 47.21 | 21963094 | |
| 23 | Ubiquitination | FGGPEVLKLRSDIAV CCCHHHEEEECCEEE | 47.21 | 21890473 | |
| 26 | Phosphorylation | PEVLKLRSDIAVPIP HHHEEEECCEEEECC | 43.75 | 28857561 | |
| 34 | 2-Hydroxyisobutyrylation | DIAVPIPKDHQVLIK CEEEECCCCCEEEEE | 69.44 | - | |
| 34 | Ubiquitination | DIAVPIPKDHQVLIK CEEEECCCCCEEEEE | 69.44 | 29967540 | |
| 34 | Malonylation | DIAVPIPKDHQVLIK CEEEECCCCCEEEEE | 69.44 | 26320211 | |
| 34 | Acetylation | DIAVPIPKDHQVLIK CEEEECCCCCEEEEE | 69.44 | 26051181 | |
| 34 | Succinylation | DIAVPIPKDHQVLIK CEEEECCCCCEEEEE | 69.44 | 27452117 | |
| 38 | Ubiquitination | PIPKDHQVLIKVHAC ECCCCCEEEEEEEEC | 5.53 | 29967540 | |
| 45 | S-nitrosylation | VLIKVHACGVNPVET EEEEEEECCCCCCHH | 3.64 | 24105792 | |
| 50 | Ubiquitination | HACGVNPVETYIRSG EECCCCCCHHHHCCC | 7.87 | 29967540 | |
| 52 | Phosphorylation | CGVNPVETYIRSGTY CCCCCCHHHHCCCCC | 25.20 | - | |
| 53 | Phosphorylation | GVNPVETYIRSGTYS CCCCCHHHHCCCCCC | 4.84 | 21253578 | |
| 62 | Ubiquitination | RSGTYSRKPLLPYTP CCCCCCCCCCCCCCC | 33.79 | 21906983 | |
| 71 | Ubiquitination | LLPYTPGSDVAGVIE CCCCCCCCCHHHHHH | 30.07 | 29967540 | |
| 71 | Acetylation | LLPYTPGSDVAGVIE CCCCCCCCCHHHHHH | 30.07 | 19608861 | |
| 88 | Ubiquitination | GDNASAFKKGDRVFT CCCHHHHHCCCEEEE | 56.41 | 21906983 | |
| 88 | Acetylation | GDNASAFKKGDRVFT CCCHHHHHCCCEEEE | 56.41 | 25038526 | |
| 88 | 2-Hydroxyisobutyrylation | GDNASAFKKGDRVFT CCCHHHHHCCCEEEE | 56.41 | - | |
| 89 | Ubiquitination | DNASAFKKGDRVFTS CCHHHHHCCCEEEEE | 60.64 | 22817900 | |
| 89 | Acetylation | DNASAFKKGDRVFTS CCHHHHHCCCEEEEE | 60.64 | 7826005 | |
| 95 | Phosphorylation | KKGDRVFTSSTISGG HCCCEEEEECEECCC | 20.93 | - | |
| 96 | Phosphorylation | KGDRVFTSSTISGGY CCCEEEEECEECCCH | 17.64 | - | |
| 97 | Phosphorylation | GDRVFTSSTISGGYA CCEEEEECEECCCHH | 27.05 | - | |
| 98 | Phosphorylation | DRVFTSSTISGGYAE CEEEEECEECCCHHH | 20.94 | - | |
| 103 | Phosphorylation | SSTISGGYAEYALAA ECEECCCHHHHHHCC | 10.37 | - | |
| 106 | Phosphorylation | ISGGYAEYALAADHT ECCCHHHHHHCCCCE | 9.95 | - | |
| 120 | 2-Hydroxyisobutyrylation | TVYKLPEKLDFKQGA EEEECCCCCCCCCCC | 51.95 | - | |
| 120 | Malonylation | TVYKLPEKLDFKQGA EEEECCCCCCCCCCC | 51.95 | 26320211 | |
| 120 | Acetylation | TVYKLPEKLDFKQGA EEEECCCCCCCCCCC | 51.95 | 23236377 | |
| 120 | Ubiquitination | TVYKLPEKLDFKQGA EEEECCCCCCCCCCC | 51.95 | 29967540 | |
| 133 | Phosphorylation | GAAIGIPYFTAYRAL CCCCCCCHHHHHHHH | 16.19 | 21406692 | |
| 135 | Phosphorylation | AIGIPYFTAYRALIH CCCCCHHHHHHHHHH | 19.55 | 21406692 | |
| 137 | Phosphorylation | GIPYFTAYRALIHSA CCCHHHHHHHHHHHH | 8.05 | 21406692 | |
| 158 | Phosphorylation | SVLVHGASGGVGLAA EEEEECCCCCHHHHH | 40.44 | 26437602 | |
| 175 | Ubiquitination | IARAYGLKILGTAGT HHHHHCCEEEEECCC | 31.36 | 29967540 | |
| 187 | Ubiquitination | AGTEEGQKIVLQNGA CCCHHHCEEEEECCC | 45.71 | 29967540 | |
| 208 | Ubiquitination | REVNYIDKIKKYVGE CCCCHHHHHHHHHHH | 47.03 | 19608861 | |
| 208 | Acetylation | REVNYIDKIKKYVGE CCCCHHHHHHHHHHH | 47.03 | 23236377 | |
| 235 | Phosphorylation | VNLSKDLSLLSHGGR CCCCCCHHHHCCCCE | 37.08 | 21406692 | |
| 238 | Phosphorylation | SKDLSLLSHGGRVIV CCCHHHHCCCCEEEE | 25.94 | 21406692 | |
| 248 | Phosphorylation | GRVIVVGSRGTIEIN CEEEEECCCCEEEEC | 18.87 | 20068231 | |
| 251 | Phosphorylation | IVVGSRGTIEINPRD EEECCCCEEEECCCC | 17.83 | 26437602 | |
| 264 | Phosphorylation | RDTMAKESSIIGVTL CCCCCCCCCEEEEEE | 26.57 | - | |
| 296 | Succinylation | GMEIGWLKPVIGSQY CCCCCCCCCCCCCCC | 30.63 | - | |
| 296 | Succinylation | GMEIGWLKPVIGSQY CCCCCCCCCCCCCCC | 30.63 | - | |
| 319 | Phosphorylation | HENIIHGSGATGKMI HHHCCCCCCCCCCEE | 15.87 | 28857561 | |
| 322 | Phosphorylation | IIHGSGATGKMILLL CCCCCCCCCCEEEEC | 40.64 | 20068231 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of QOR_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of QOR_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of QOR_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| G3P_HUMAN | GAPDH | physical | 22863883 | |
| TBA4A_HUMAN | TUBA4A | physical | 22863883 | |
| TBB5_HUMAN | TUBB | physical | 22863883 | |
| TRXR1_HUMAN | TXNRD1 | physical | 22863883 | |
| CAB39_HUMAN | CAB39 | physical | 26344197 | |
| DCXR_HUMAN | DCXR | physical | 26344197 | |
| LEG3_HUMAN | LGALS3 | physical | 26344197 | |
| NNMT_HUMAN | NNMT | physical | 26344197 | |
| SMAP2_HUMAN | SMAP2 | physical | 26344197 |
| Kegg Disease | |
|---|---|
| There are no disease associations of PTM sites. | |
| OMIM Disease | |
| There are no disease associations of PTM sites. | |
| Kegg Drug | |
| There are no disease associations of PTM sites. | |
| DrugBank | |
| DB00266 | Dicoumarol |
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-23 AND LYS-208, AND MASSSPECTROMETRY. | |